Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CLOZAPINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2532 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Raggi, MA; Pucci, V; Sabbioni, C; Furlanetto, S; Gerra, G
      Simultaneous determination of plasma catecholamine metabolites (homovanillic acid, 3,4-dihydroxy phenyl acetic acid, 3-methoxy-4-hydroxy-phenylglycol) using liquid chromatography with amperometric detection

      JOURNAL OF SEPARATION SCIENCE
    2. Berlind, A
      Effects of haloperidol and phentolamine on the crustacean cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    3. Berlind, A
      Monoamine pharmacology of the lobster cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    4. Smith, RC; Infante, M; Singh, A; Khandat, A
      The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    5. Reitzle, K; Warnke, A; Wewetzer, C; Muller, H
      Agranulocytosis in a schizophrenic child receiving clozapine therapy - clinical picture and therapy. a case report

      ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE
    6. Weigmann, H; Hartter, S; Maehrlein, S; Kiefer, W; Kramer, G; Dannhardt, G; Hiemke, C
      Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    7. Llerena, A; Berecz, R; Norberto, MJ; de la Rubia, A
      Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    8. Procyshyn, RM; Flynn, S
      Discharge prescribing practices: Comparing a research ward to general treatment wards

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    9. Horacek, J; Libiger, J; Hoschl, C; Borzova, K; Hendrychova, I
      Clozapine-induced concordant agranulocytosis in monozygotic twins

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    10. Segman, RH; Heresco-Levy, U; Finkel, B; Goltser, T; Shalem, R; Schlafman, M; Dorevitch, A; Yakir, A; Greenberg, D; Lerner, A; Lerer, B
      Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

      MOLECULAR PSYCHIATRY
    11. Basile, VS; Ozdemir, V; Masellis, M; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, FM; Petronis, A; Kennedy, JL
      Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    12. Arias, B; Gutierrez, B; Pintor, L; Gasto, C; Fananas, L
      Variability in the 5-MT2A receptor gene is associated with seasonal pattern in major depression

      MOLECULAR PSYCHIATRY
    13. Boin, F; Zanardini, R; Pioli, R; Altamura, CA; Maes, M; Gennarelli, M
      Association between-G308A tumor necrosis factor alpha gene polymorphism and schizophrenia

      MOLECULAR PSYCHIATRY
    14. Purdon, SE; Woodward, ND; Flor-Henry, P
      Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    15. Risch, SC; McGurk, S; Horner, MD; Nahas, Z; Owens, SD; Molloy, M; Gilliard, C; Christie, S; Markowitz, JS; DeVane, CL; Mintzer, J; George, MS
      A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: Functional MRI correlates

      NEUROCASE
    16. Emsley, R; Oosthuizen, P; Niehaus, D; Stein, D
      Anxiety symptoms in schizophrenia: the need for heightened clinician awareness

      PRIMARY CARE PSYCHIATRY
    17. Gimenez-Roldan, S; Mateo, D; Navarro, E; Gines, MM
      Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis

      PARKINSONISM & RELATED DISORDERS
    18. Wolters, EC; Berendse, HW
      Management of psychosis in Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    19. Ananth, J; Burgoyne, KS; Gadasalli, R; Aquino, S
      How do the atypical antipsychotics work?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    20. Gobbi, G; Pulvirenti, L
      Long-term treatment with dozapine in an adult with autistic disorder accompanied by aggressive behaviour

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    21. Tempier, R; Pawliuk, N
      Influence of novel and conventional antipsychotic medication on subjectivequality of life

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    22. Purdon, SE; Malla, A; Labelle, A; Lit, W
      Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    23. Khullar, A; Chue, P; Tibbo, P
      Quetiapine and obsessive-compulsive symptoms (OCS): case report and reviewof atypical antipsychotic-induced OCS

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    24. Tauscher, J; Kapur, S
      Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies

      CNS DRUGS
    25. Russell, JM; Mackell, JA
      Bodyweight gain associated with atypical antipsychotics - Epidemiology andtherapeutic implications

      CNS DRUGS
    26. Arranz, MJ; Mancama, D; Kerwin, RW
      Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    27. Hirose, S; Ashby, CR; Mills, MJ
      Effectiveness of ECT combined with risperidone against aggression in schizophrenia

      JOURNAL OF ECT
    28. Baillargeon, J; Contreras, SA
      Antipsychotic prescribing patterns in the texas prison system

      JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW
    29. Trestman, RL
      Commentary: Antipsychotic prescribing practices in the Texas prison system

      JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW
    30. Escamilla, M
      Diagnosis and treatment of mood disorders that co-occur with schizophrenia

      PSYCHIATRIC SERVICES
    31. Mellman, TA; Miller, AL; Weissman, EM; Crismon, ML; Essock, SM; Marder, SR
      Evidence-based pharmacologic treatment for people with severe mental illness: A focus on guidelines and algorithms

      PSYCHIATRIC SERVICES
    32. Noordsy, DL; O'Keefe, C; Mueser, KT; Xie, HY
      Six-month outcomes for patients who switched to olanzapine treatment

      PSYCHIATRIC SERVICES
    33. Tang, WK; Ungvari, GS
      Rehab rounds - Electroconvulsive therapy in rehabilitation: The Hong Kong experience

      PSYCHIATRIC SERVICES
    34. Geller, JL
      The case of Sam: Multidisciplinary perspectives

      PSYCHIATRIC SERVICES
    35. Osser, DN; Sigadel, R
      Short-term inpatient pharmacotherapy of schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    36. Salzman, C; Tune, L
      Neuroleptic treatment of late-life schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    37. Patel, JK; Caplan, B; Green, A; Tamminga, C
      First-episode psychosis: Critical management issues during the first two years

      HARVARD REVIEW OF PSYCHIATRY
    38. Alfaro, CL; McClure, RK; Vertrees, JE; Benavides, R
      Unanticipated plasma concentrations in two clozapine-treated patients

      ANNALS OF PHARMACOTHERAPY
    39. Hoehns, JD; Fouts, MM; Kelly, MW; Tu, KB
      Sudden cardiac death with clozapine and sertraline combination

      ANNALS OF PHARMACOTHERAPY
    40. English, BA; Still, DJ; Harper, J; Saklad, SR
      Failure of tolterodine to treat clozapine-induced nocturnal enuresis

      ANNALS OF PHARMACOTHERAPY
    41. Garcia, G; Ghani, S; Poveda, RA; Dansky, BL
      Neuroleptic malignant syndrome with antidepressant/antipsychotic drug combination

      ANNALS OF PHARMACOTHERAPY
    42. Farver, DK; Khan, MH
      Zolpidem for antipsychatic-induced parkinsonism

      ANNALS OF PHARMACOTHERAPY
    43. Sajbel, TA; Carter, GW; Wiley, RB
      Converting patients from brand-name clozapine to generic clozapine

      ANNALS OF PHARMACOTHERAPY
    44. Zerjav-Lacombe, S; Dewan, V
      Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine

      ANNALS OF PHARMACOTHERAPY
    45. Avram, AM; Patel, V; Taylor, HC; Kirwan, JP; Kalhan, S
      Euglycemic clamp study in clozapine-induced diabetic ketoacidosis

      ANNALS OF PHARMACOTHERAPY
    46. Albanese, MJ
      Safety and efficacy of risperidone in substance abusers with psychosis

      AMERICAN JOURNAL ON ADDICTIONS
    47. Lisman, JE; Otmakhova, NA
      Storage, recall, and novelty detection of sequences by the hippocampus: Elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine

      HIPPOCAMPUS
    48. Reuss, B; Unsicker, K
      Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes

      MOLECULAR AND CELLULAR NEUROSCIENCE
    49. Spivak, B; Mozes, T; Mester, R; Kodelik, M; Weizman, A
      Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: An open-label study

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    50. Domon, SE; Webber, JC
      Hyperglycemia and hypertriglyceridemia secondary to olanzapine

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    51. Parraga, HC; Parraga, MI; Woodward, RL; Fenning, PA
      Quetiapine treatment of children with Tourette's syndrome: Report of two cases

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    52. Lachar, D; Bailley, SE; Rhoades, HM; Espadas, A; Aponte, M; Cowan, KA; Gummattira, P; Kopecky, CR; Wassef, A
      New subscales for an anchored version of the Brief Psychiatric Rating Scale: Construction, reliability, and validity in acute psychiatric admissions

      PSYCHOLOGICAL ASSESSMENT
    53. Golimbet, VE; Alfimova, MV; Manandyan, KK; Mitushina, NG; Abramova, LI; Kaleda, VG; Oleichik, IV; Yurov, YB; Trubnikov, VI
      Serotonin type 2a (5-HTR2A) receptor gene polymorphism and personality traits in patients with major psychoses

      RUSSIAN JOURNAL OF GENETICS
    54. Matloubi, H; Ghandi, M; Zarrindast, MR; Saemian, N
      Modified synthesis of 11-[C-14]-clozapine

      APPLIED RADIATION AND ISOTOPES
    55. Scapecchi, S; Marucci, G; Matucci, R; Angeli, P; Bellucci, C; Buccioni, M; Dei, S; Gualtieri, F; Manetti, D; Romanelli, MN; Teodori, E
      Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: Unexpected agonistic activity in a series of muscarinic antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY
    56. Hodgetts, KJ; Kieltyka, A; Brodbeck, R; Tran, JN; Wasley, JWF; Thurkauf, A
      6-(4-benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D-4 receptors

      BIOORGANIC & MEDICINAL CHEMISTRY
    57. Erbagci, AB; Herken, H; Koyluoglu, O; Yilmaz, N; Tarakcioglu, M
      Serum IL-1 beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

      MEDIATORS OF INFLAMMATION
    58. Niesler, B; Flohr, T; Nothen, MM; Fischer, C; Rietschel, M; Franzek, E; Albus, M; Propping, P; Rappold, GA
      Association between the 5 ' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder

      PHARMACOGENETICS
    59. Hong, CJ; Lin, CH; Yu, YWY; Yang, KH; Tsai, SJ
      Genetic variants of the serotonin system and weight change during clozapine treatment

      PHARMACOGENETICS
    60. Dettling, M; Schaub, RT; Mueller-Oerlinghausen, B; Roots, I; Cascorbi, I
      Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry

      PHARMACOGENETICS
    61. See, RE; Berglind, WJ
      Decreased pallidal GABA following reverse microdialysis with, clozapine, but not haloperidol

      NEUROREPORT
    62. Qiao, H; Noda, Y; Kamei, H; Nagai, T; Furukawa, H; Miura, H; Kayukawa, Y; Ohta, T; Nabeshima, T
      Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment

      NEUROREPORT
    63. Linn, GS; Javitt, DC
      Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys

      NEUROREPORT
    64. Goudie, AJ; Baker, LE; Smith, JA; Prus, AJ; Svensson, KA; Cortes-Burgos, LA; Wong, EHF; Haadsma-Svensson, S
      Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D-3 preferring antagonist PNU-99194A: an analysis of possible mechanisms

      BEHAVIOURAL PHARMACOLOGY
    65. Shiigi, Y; Casey, DE
      Effects of benztropine on ketamine-induced behaviors in Cebus monkeys

      BEHAVIOURAL PHARMACOLOGY
    66. Naidu, PS; Kulkarni, SK
      Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide

      BEHAVIOURAL PHARMACOLOGY
    67. Palmblad, J; Papadaki, HA; Eliopoulos, G
      Acute and chronic neutropenias. What is new?

      JOURNAL OF INTERNAL MEDICINE
    68. Lipska, BK; Khaing, ZZ; Weickert, CS; Weinberger, DR
      BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs

      EUROPEAN JOURNAL OF NEUROSCIENCE
    69. Owen, GS; Halliwell, JV
      Electrophysiological characterization of laminar synaptic inputs to the olfactory tubercle of the rat studied in vitro: modulation of glutamatergic transmission by cholinergic agents is pathway-specific

      EUROPEAN JOURNAL OF NEUROSCIENCE
    70. Ovalle, S; Zamanillo, D; Andreu, F; Farre, AJ; Guitart, X
      Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic

      EUROPEAN JOURNAL OF NEUROSCIENCE
    71. Hempel, AG; Cormack, TS
      Treatment of the mentally disordered offender

      CURRENT OPINION IN PSYCHIATRY
    72. Malhotra, AK
      The genetics of schizophrenia

      CURRENT OPINION IN PSYCHIATRY
    73. Fenton, WS
      Comorbid conditions in schizophrenia

      CURRENT OPINION IN PSYCHIATRY
    74. Barnes, TRE; Joyce, EM
      Antipsychotic drug treatment: recent advances

      CURRENT OPINION IN PSYCHIATRY
    75. Markianos, M; Hatzimanolis, J; Lykouras, L
      Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    76. Bernardo, M; Parellada, E; Lomena, F; Catafau, AM; Font, M; Gomez, JC; Lopez-Carrero, C; Gutierrez, F; Pavia, J; Salamero, M
      Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [I-123]IBZM SPECT study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    77. Melkersson, K; Khan, A; Hilding, A; Hulting, AL
      Different effects of antipsychotic drugs on insulin release in vitro

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    78. Gefvert, O; Lundberg, T; Wieselgren, IM; Bergstrom, M; Langstrom, B; Wiesel, FA; Lindstrom, L
      D-2 and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    79. Schreinzer, D; Frey, R; Stimpfl, T; Vycudilik, W; Berzlanovich, A; Kasper, S
      Different fatal toxicity of neuroleptics identified by autopsy

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    80. Liebzeit, KA; Markowitz, JS; Caley, CF
      New onset diabetes and atypical antipsychotics

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    81. Naber, D; Karow, A
      Good tolerability equals good results: the patient's perspective

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    82. Lynch, J; Morrison, J; Graves, N; Meddis, D; Drummond, MF; Hellewell, JSE
      The health economic implications of treatment with quetiapine: an audit oflong-term treatment for patients with chronic schizophrenia

      EUROPEAN PSYCHIATRY
    83. Mauri, MC; Laini, V; Boscati, L; Rudelli, R; Salvi, V; Orlandi, R; Papa, P
      Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels

      EUROPEAN PSYCHIATRY
    84. Huppert, JD; Weiss, KA; Lim, R; Pratt, S; Smith, TE
      Quality of life in schizophrenia: contributions of anxiety and depression

      SCHIZOPHRENIA RESEARCH
    85. Kowalski, J; Blada, P; Kucia, K; Madej, A; Herman, ZS
      Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia

      SCHIZOPHRENIA RESEARCH
    86. Knott, V; Labelle, A; Jones, B; Mahoney, C
      Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment

      SCHIZOPHRENIA RESEARCH
    87. Ganguli, R; Brar, JS; Ayrton, Z
      Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone

      SCHIZOPHRENIA RESEARCH
    88. Tsai, SJ; Wang, YC; Younger, WYY; Lin, CH; Yang, KH; Hong, CJ
      Association analysis of polymorphism in the promoter region of the alpha 2a-adrenoceptor gene with schizophrenia and clozapine response

      SCHIZOPHRENIA RESEARCH
    89. Frodl, T; Meisenzahl, EM; Muller, D; Greiner, J; Juckel, G; Leinsinger, G; Hahn, H; Moller, HJ; Hegerl, U
      Corpus callosum and P300 in schizophrenia

      SCHIZOPHRENIA RESEARCH
    90. Rasmussen, T; Fink-Jensen, A; Sauerberg, P; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP
      The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

      SCHIZOPHRENIA RESEARCH
    91. Konicki, PE; Kwon, KY; Steele, V; White, J; Fuller, M; Jurjus, GJ; Jaskiw, GE
      Prefrontal cortical sulcal widening associated with poor treatment response to clozapine

      SCHIZOPHRENIA RESEARCH
    92. Cuesta, MJ; Peralta, V; Zarzuela, A
      Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

      SCHIZOPHRENIA RESEARCH
    93. Purdon, SE; Labelle, A; Boulay, L
      Neuropsychological change in schizophrenia after 6 weeks of clozapine

      SCHIZOPHRENIA RESEARCH
    94. Farah, A
      Reduction of tardive dyskinesia with quetiapine

      SCHIZOPHRENIA RESEARCH
    95. Masellis, M; Basile, VS; Meltzer, HY; Lieberman, JA; Sevy, S; Goldman, DA; Hamblin, MW; Macciardi, FM; Kennedy, JL
      Lack of association between the T -> C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia

      SCHIZOPHRENIA RESEARCH
    96. Gjere, NA
      Psychopharmacology in pregnancy

      JOURNAL OF PERINATAL & NEONATAL NURSING
    97. Wadenberg, MLG; Soliman, A; VanderSpek, SC; Kapur, S
      Dopamine D-2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects

      NEUROPSYCHOPHARMACOLOGY
    98. Gur, RC; Ragland, JD; Moberg, PJ; Bilker, WB; Kohler, C; Siegel, SJ; Gur, RE
      Computerized neurocognitive scanning: II. The profile of schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    99. Scheepers, FE; Wied, CCG; Westenberg, HGM; Kahn, RS
      The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients

      NEUROPSYCHOPHARMACOLOGY
    100. Audinot, V; Newman-Tancredi, A; Cussac, D; Millan, MJ
      Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors

      NEUROPSYCHOPHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 10:15:42